Hospital Dia do Pulmao

Blumenau, Santa Catarina 89030-101

0 studies enrolling now · 2 studies all time

What they study most

COVID-19, Idiopathic Pulmonary Fibrosis, Systemic Sclerosis With Lung Involvement

Studies at this site

• A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease — Stopped early
• Evaluation of Protease Inhibition for COVID-19 in Standard-Risk Patients (EPIC-SR). — Stopped early